IL232608A0 - Cysteamine and/or cysteamine for the treatment of ischemic injury - Google Patents
Cysteamine and/or cysteamine for the treatment of ischemic injuryInfo
- Publication number
- IL232608A0 IL232608A0 IL232608A IL23260814A IL232608A0 IL 232608 A0 IL232608 A0 IL 232608A0 IL 232608 A IL232608 A IL 232608A IL 23260814 A IL23260814 A IL 23260814A IL 232608 A0 IL232608 A0 IL 232608A0
- Authority
- IL
- Israel
- Prior art keywords
- cystamine
- cysteamine
- ischemic injury
- treating ischemic
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161563034P | 2011-11-22 | 2011-11-22 | |
| PCT/US2012/066288 WO2013078335A1 (en) | 2011-11-22 | 2012-11-21 | Cysteamine and/or cystamine for treating ischemic injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL232608A0 true IL232608A0 (en) | 2014-06-30 |
Family
ID=47297472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL232608A IL232608A0 (en) | 2011-11-22 | 2014-05-14 | Cysteamine and/or cysteamine for the treatment of ischemic injury |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140322315A1 (enExample) |
| EP (1) | EP2782564B1 (enExample) |
| JP (1) | JP6411215B2 (enExample) |
| KR (1) | KR20140097132A (enExample) |
| CN (2) | CN103974698A (enExample) |
| AU (1) | AU2012340670B2 (enExample) |
| BR (1) | BR112014012167A2 (enExample) |
| CA (1) | CA2851387A1 (enExample) |
| HK (1) | HK1202440A1 (enExample) |
| IL (1) | IL232608A0 (enExample) |
| MX (1) | MX2014004469A (enExample) |
| MY (1) | MY165953A (enExample) |
| RU (1) | RU2638807C2 (enExample) |
| SG (2) | SG11201402472QA (enExample) |
| WO (1) | WO2013078335A1 (enExample) |
| ZA (1) | ZA201402290B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR096628A1 (es) * | 2013-06-17 | 2016-01-20 | Raptor Pharmaceuticals Inc | Formulación en perlas de cisteamina de liberación retardada y métodos de preparación y uso de ella |
| TWI759267B (zh) | 2015-07-02 | 2022-04-01 | 美商地平線罕見醫學製藥有限責任公司 | Ａｄｏ抗性半胱胺類似物及其用途 |
| CN106591461A (zh) * | 2016-12-29 | 2017-04-26 | 天津协和华美医学诊断技术有限公司 | 一种检测遗传性易栓症相关基因群的检测试剂盒 |
| CN110392568A (zh) | 2017-01-19 | 2019-10-29 | 耳科制药公司 | N-乙酰半胱氨酸的制剂及其用途 |
| MX2019008847A (es) * | 2017-01-25 | 2019-12-16 | Adare Pharmaceuticals Inc | Profarmacos de cisteamina. |
| WO2021022012A1 (en) * | 2019-07-30 | 2021-02-04 | The Regents Of The University Of California | Methods and composition for treating respiratory obstructive diseases |
| CN113484453B (zh) * | 2021-07-07 | 2022-08-09 | 天津中医药大学 | 一种缺血性脑卒中预警方法 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2809918A (en) | 1955-10-17 | 1957-10-15 | Victor M Hermelin | Sustained release pharmaceutical preparations |
| DE2010416B2 (de) | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
| FR2471186A1 (fr) | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
| US4301146A (en) | 1980-07-29 | 1981-11-17 | G. D. Searle & Co. | Stabilization of 16-oxygenated prostanoic acid derivatives |
| FR2549051B1 (fr) | 1983-06-22 | 1986-05-16 | Centre Nat Rech Scient | Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procede pour leur preparation |
| FR2573077B1 (fr) * | 1984-11-13 | 1987-02-13 | Sanofi Sa | Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant |
| US4728512A (en) | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
| US4794001A (en) | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
| KR890004692A (ko) * | 1987-09-08 | 1989-05-09 | 스야마 타다카즈 | 혈소판 응지억제제 |
| JPH02243619A (ja) * | 1989-03-15 | 1990-09-27 | Green Cross Corp:The | 抗血小板凝集剤 |
| SK232890A3 (en) | 1989-05-17 | 1998-11-04 | Pfizer | 2-piperidino and 2-pyrrolidino-1-alkanols derivatives and preparation method thereof |
| US5225202A (en) | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
| US5436255A (en) | 1992-07-23 | 1995-07-25 | Pfizer Inc. | Method of treating diseases susceptable to treatment by blocking NMDA-receptors |
| TW281670B (enExample) | 1993-09-02 | 1996-07-21 | Hoffmann La Roche | |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| WO1997023202A1 (en) | 1995-12-22 | 1997-07-03 | STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITYA ND THE UNIVERSITY OF OREGON, EUGENE OREGON | Subtype-selective nmda receptor ligands and the use thereof |
| ZA9610745B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| US6087398A (en) * | 1996-03-01 | 2000-07-11 | South Alabama Medical Science Foundation | Sickle cell anemia treatment |
| FR2753098B1 (fr) * | 1996-09-06 | 1998-11-27 | Sod Conseils Rech Applic | Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene |
| DE19643790A1 (de) | 1996-10-30 | 1998-05-07 | Merck Patent Gmbh | Benzoxazol-Derivat |
| NZ502785A (en) | 1997-10-24 | 2003-03-28 | Warner Lambert Co | Use of NR1A/2B site-selective NMDA receptor antagonist compounds for treating disease-related or drug-induced dyskinesias |
| PE20000728A1 (es) | 1998-06-26 | 2000-08-21 | Cocensys Inc | Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda |
| AU1808100A (en) | 1998-10-28 | 2000-05-15 | Vitaly V. Romanenko | Electrodynamic particle size analyzer |
| US6476041B1 (en) | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| US6316474B1 (en) | 1999-10-29 | 2001-11-13 | Merck & Co., Inc. | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
| US6432976B1 (en) | 1999-10-29 | 2002-08-13 | Merck & Co., Inc. | 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists |
| WO2001030330A2 (en) | 1999-10-29 | 2001-05-03 | Merck Sharp & Dohme Limited | Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| US6369076B1 (en) | 1999-10-29 | 2002-04-09 | Merck & Co. Inc. | 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists |
| US6489477B1 (en) | 1999-10-29 | 2002-12-03 | Merck & Co., Inc. | 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists |
| US6291499B1 (en) | 1999-10-29 | 2001-09-18 | Merck & Co., Inc. | 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
| ATE515261T1 (de) * | 2003-12-19 | 2011-07-15 | Omega Bio Pharma Ip3 Ltd | Zusammensetzungen zur behandlung von diabetes |
| CN1976691B (zh) * | 2004-05-03 | 2010-10-13 | 奥加生物药业(I.P.3)有限公司 | 半胱胺用于治疗高胆固醇血症和糖尿病并发症 |
| EP2214480B1 (en) * | 2007-11-30 | 2013-03-27 | The Regents of the University of California | Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
| RU2428192C1 (ru) * | 2010-06-10 | 2011-09-10 | Войсковая Часть 41598 | Радиозащитное средство |
-
2012
- 2012-11-21 SG SG11201402472QA patent/SG11201402472QA/en unknown
- 2012-11-21 CN CN201280057439.7A patent/CN103974698A/zh active Pending
- 2012-11-21 RU RU2014125282A patent/RU2638807C2/ru not_active IP Right Cessation
- 2012-11-21 CN CN201810067673.7A patent/CN108042517A/zh active Pending
- 2012-11-21 HK HK15103104.0A patent/HK1202440A1/xx unknown
- 2012-11-21 JP JP2014542590A patent/JP6411215B2/ja not_active Expired - Fee Related
- 2012-11-21 BR BR112014012167A patent/BR112014012167A2/pt not_active IP Right Cessation
- 2012-11-21 EP EP12798116.5A patent/EP2782564B1/en not_active Not-in-force
- 2012-11-21 MY MYPI2014001446A patent/MY165953A/en unknown
- 2012-11-21 US US14/360,095 patent/US20140322315A1/en not_active Abandoned
- 2012-11-21 CA CA2851387A patent/CA2851387A1/en not_active Abandoned
- 2012-11-21 SG SG10201800159QA patent/SG10201800159QA/en unknown
- 2012-11-21 WO PCT/US2012/066288 patent/WO2013078335A1/en not_active Ceased
- 2012-11-21 AU AU2012340670A patent/AU2012340670B2/en not_active Ceased
- 2012-11-21 MX MX2014004469A patent/MX2014004469A/es unknown
- 2012-11-21 KR KR1020147010492A patent/KR20140097132A/ko not_active Ceased
-
2014
- 2014-03-27 ZA ZA2014/02290A patent/ZA201402290B/en unknown
- 2014-05-14 IL IL232608A patent/IL232608A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103974698A (zh) | 2014-08-06 |
| CA2851387A1 (en) | 2013-05-30 |
| US20140322315A1 (en) | 2014-10-30 |
| RU2014125282A (ru) | 2015-12-27 |
| HK1202440A1 (zh) | 2015-10-02 |
| MY165953A (en) | 2018-05-18 |
| AU2012340670A1 (en) | 2014-04-17 |
| EP2782564B1 (en) | 2019-01-09 |
| BR112014012167A2 (pt) | 2017-05-30 |
| CN108042517A (zh) | 2018-05-18 |
| WO2013078335A1 (en) | 2013-05-30 |
| SG11201402472QA (en) | 2014-06-27 |
| MX2014004469A (es) | 2014-08-01 |
| ZA201402290B (en) | 2017-06-28 |
| KR20140097132A (ko) | 2014-08-06 |
| SG10201800159QA (en) | 2018-02-27 |
| RU2638807C2 (ru) | 2017-12-15 |
| AU2012340670B2 (en) | 2016-12-22 |
| JP2014533701A (ja) | 2014-12-15 |
| JP6411215B2 (ja) | 2018-10-24 |
| EP2782564A1 (en) | 2014-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3269A (en) | Methods and compounds for treating paramyxoviridaevirus infections | |
| IL238416A0 (en) | Preparations and methods for the treatment of diseases caused by protein pathology | |
| PT2948448T (pt) | Análogos de tiadiazol e o seu uso para tratamento de doenças associadas a uma deficiência de neurónios motores smn | |
| EP2757887A4 (en) | PYRROLOPYRIDINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF HIV | |
| ZA201505390B (en) | Compositions and methods for treating pests | |
| HUE039560T2 (hu) | Mikro méretû zárófedés és kapcsolódó eljárások bõr kezelésére | |
| DK3292875T3 (en) | Compositions and methods for treating diseases | |
| GB201004172D0 (en) | Skin treating device | |
| IL226258A0 (en) | Lipoyl compounds and their use in the treatment of ischemic injury | |
| IL232608A0 (en) | Cysteamine and/or cysteamine for the treatment of ischemic injury | |
| ZA201500248B (en) | Method and device for reinforcing and/or lining material | |
| ZA201303222B (en) | Composition and method for treating skin conditions | |
| LT2718434T (lt) | Kompozicijos ir būdai, skirti celiakijos gydymui | |
| SG10201710538XA (en) | Compositions and methods for treating skin | |
| EP2916767A4 (en) | DEVICES FOR TREATING TEETH NECKS | |
| ZA201306613B (en) | Combinations comprising macitentan for the treatment of glioblastoma multiforme | |
| SG11201405559TA (en) | Component and method for treating viral disease | |
| EP2919856A4 (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF GASTRO-SOPHAGEAL DISORDERS | |
| PL3001842T3 (pl) | Materiał do obróbki powierzchniowej i jego zastosowanie | |
| IL238331A0 (en) | A method for treating type I and type II diabetes | |
| PL2727720T3 (pl) | Materiał warstwowy i sposób obróbki cieplnej materiału warstwowego | |
| PL2768527T3 (pl) | Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 | |
| ZA201302565B (en) | Methods for treating hyperuricemia and related diseases | |
| IL213610A0 (en) | Composition for treating dermatological conditions | |
| ZA201408732B (en) | Composition and methods for treating wounds |